<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <title>Research Statement — Santosh Gothwal</title>

    <link rel="stylesheet" href="assets/css/tailwind.css">
    <link href="https://fonts.googleapis.com/css2?family=Montserrat&display=swap" rel="stylesheet">

    <style>
        body {
            font-family: 'Montserrat', sans-serif;
        }
    </style>
</head>

<body class="flex flex-col min-h-screen bg-white">

    <!-- NAVBAR -->
    <div id="navbar"></div>

    <!-- MAIN CONTENT -->
    <main class="pt-28 pb-16 px-6">

        <div class="max-w-5xl mx-auto">

            <!-- Page Title -->
            <h1 class="text-3xl md:text-4xl font-bold text-gray-900 mb-6">
                Research Statement: Personalized Cancer Chemotherapy
            </h1>

            <!-- Hero Image -->
            <div class="rounded-3xl overflow-hidden shadow mb-10">
                <img src="images/statement/statement.png" class="w-full object-cover"
                    alt="Research statement illustration">
            </div>

            <!-- ================= CONTENT CARD ================= -->
            <div class="bg-[#EDEEE7] rounded-3xl p-8 md:p-12 shadow leading-relaxed text-gray-900">

                <!-- Lead Paragraph -->
                <p class="mb-8 text-lg md:text-xl
            first-letter:text-5xl first-letter:font-bold
            first-letter:pr-1 first-letter:float-left">
                    Chemotherapeutic responses in cancer are strongly influenced by DNA
                    mutations within tumor cells. Gene mutations can disrupt key cellular
                    pathways and alter treatment outcomes. Most approved chemotherapeutic
                    agents fall into three major categories:
                    DNA replication inhibitors (e.g., Gemcitabine, Hydroxyurea),
                    DNA repair inhibitors (including DNA-PK, NHEJ, and HR inhibitors),
                    and modulators of histone modifications triggered by the DNA damage
                    response.
                    By understanding how these mutations interact with drug-induced
                    cellular stress, it becomes possible to develop targeted therapies
                    with greater sensitivity and improved safety profiles — overcoming
                    many of the limitations associated with current chemotherapeutic agents.
                </p>

                <!-- Divider -->
                <div class="border-t border-gray-300 my-8"></div>

                <!-- Section 2 -->
                <p class="mb-6">
                    Drug response can vary widely depending on mutation-driven
                    gain- or loss-of-function alterations in cancer cells.
                    For example, mutations in <strong>TP53</strong> — one of the most
                    frequently mutated tumor suppressors in human cancers —
                    can promote resistance to chemotherapy.
                    Similarly, excessive single-stranded DNA formation may enhance
                    homologous recombination (HR), resulting in resistance to
                    Poly(ADP-ribose) polymerase (PARP) inhibitors currently used
                    in BRCA1/2-mutant breast cancers.
                </p>

                <!-- Section 3 -->
                <p class="mb-6">
                    Additional mutations affecting DNA repair factors — including
                    HR, non-homologous end joining (NHEJ), and DNA replication
                    pathways — may also promote drug resistance through mechanisms such as:
                    compensatory DNA repair activity,
                    R-loop accumulation,
                    oncogene hyperactivation,
                    impaired apoptosis,
                    altered ubiquitin-ligase function,
                    and dysregulated metastatic signaling.
                    Collectively, these adaptations weaken the effectiveness
                    of conventional chemotherapeutic strategies.
                </p>

                <!-- Pull Quote -->
                <blockquote class="bg-white rounded-2xl border-l-4 border-gray-500
                     p-6 my-10 italic text-lg text-gray-700">
                    “Personalized chemotherapy begins with decoding
                    mutation-driven vulnerabilities within each tumor.”
                </blockquote>

                <!-- Section 4 -->
                <p class="mb-6">
                    Current chemotherapy regimens for cancers such as lung cancer,
                    breast cancer, and cholangiocarcinoma still rely heavily on
                    broadly acting agents like gemcitabine and etoposide, without
                    sufficient molecular precision. In contrast, personalized cancer
                    medicine — including mutation-guided therapies and selective
                    immunotherapies — represents the future of oncology.
                </p>

                <!-- Closing -->
                <p>
                    The long-term goal of this research is to develop systems capable
                    of classifying tumor-specific mutations in individual patients
                    and predicting optimal drug combinations <em>before</em>
                    treatment is initiated. Such precision tools will support
                    clinical decision-making, extend patient survival, and reduce
                    toxicity to healthy tissues — advancing the broader vision of
                    personalized chemotherapy and precision oncology.
                </p>

            </div>
        </div>

    </main>

    <!-- FOOTER -->
    <div id="footer"></div>

    <!-- LOAD NAVBAR + FOOTER -->
    <script src="common/include.js"></script>

    <script>
        loadHTML("navbar", "common/navbar.html").then(() => {

            const navToggle = document.getElementById('navToggle');
            const mobileMenu = document.getElementById('mobileMenu');
            const backdrop = document.getElementById('backdrop');

            function openMenu() {
                mobileMenu.classList.remove('scale-y-0', 'opacity-0');
                mobileMenu.classList.add('scale-y-100', 'opacity-100');
                backdrop.classList.remove('opacity-0', 'pointer-events-none');
            }

            function closeMenu() {
                mobileMenu.classList.add('scale-y-0', 'opacity-0');
                mobileMenu.classList.remove('scale-y-100', 'opacity-100');
                backdrop.classList.add('opacity-0', 'pointer-events-none');
            }

            navToggle?.addEventListener('click', () => {
                const isOpen = mobileMenu.classList.contains('scale-y-100');
                isOpen ? closeMenu() : openMenu();
            });

            backdrop?.addEventListener('click', closeMenu);
        });

        loadHTML("footer", "common/footer.html");
    </script>

</body>

</html>